AptaTargets aptatargets.com


Public list: Pharma Startups (6570) Cancer Therapeutics (1180)

AptaTargets is a biopharmaceutical company focused on developing therapeutic applications based on aptamer technology. AptaTarget's drug candidates come from R&D activities in collaboration with research centers of reference. The company specializes in aptamers, DNA, or RNA molecules that can recognize and bond with specific therapeutic targets and are an alternative to antibodies. The first product being developed with these molecules is ApTOLL, an immunomodulatory molecule that could help redu...Show all

AptaTargets is a biopharmaceutical company focused on developing therapeutic applications based on aptamer technology. AptaTarget's drug candidates come from R&D activities in collaboration with research centers of reference. The company specializes ...Show all

Company (Alive / Active)

All investors data 5 Investors

Phone: +34 91 007 56 22

Fax:

Avda. Cardenal Herrera Oria, 298

 Madrid, 28035
 Spain

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
AptaTargets $8.9M Oct 14, 2020

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related AptaTargets Jobs

jobs by Indeed job search

Investors

Investor Investor Type Location Participating Rounds
See all 5 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Aptamers specific for tlr-4 and uses thereof Dec 14, 2018 Oct 20, 2020 Patent
Aptamers specific for tlr-4 and uses thereof Jun 24, 2015 Feb 05, 2019 Patent